Medical Communications

Showing 15 posts of 6402 posts found.

kress

Biogen appoint new Head of Global Therapeutic Operations

June 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Jean-Paul Kress

Biogen announced that Jean-Paul Kress has been appointed to the position of Executive Vice President and President, International, and Head …
novartis_side_building

UK launch of two Novartis biosimilars could cut NHS costs

June 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erelzi, Novartis, Rixathon, Sandoz, biosimilar, etanercept, rituximab

Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …
filing_cabinet

Number of patients at risk from NHS mail mistake revealed

June 27, 2017 Manufacturing and Production, Medical Communications Department of Health, Jeremy Hunt, NHS, NHS England

According to the patient records that have been examined so far, at least 1,700 may have been put at risk …
shutterstock_57369385

Drug Combinations and Emerging Interactions

June 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug combinations, drug resistance, feature

Pamela Yeh, Assistant Professor at the Department of Ecology and Evolutionary Biology, University of California, Los Angeles, discusses how drug …
nhs_parliament_2_4

Public dissatisfaction with NHS found to be growing, says BMA

June 26, 2017 Medical Communications, Sales and Marketing BMA, NHS

The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with …

Astellas receives further year suspension from ABPI

June 26, 2017 Medical Communications, Sales and Marketing ABPI, Astellas

The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …

Pfizer’s biosimilar gets a second knock-back from FDA

June 23, 2017 Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …
novartis_outside_1

Novartis lung cancer combo receives FDA approval

June 23, 2017 Medical Communications, Sales and Marketing NSCLC, Novartis

Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …
needle-1291170_960_720

HIV cases in gay men fall for the first time in England

June 23, 2017 Medical Communications HIV, PrEP

For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was …
shutterstock_187433765

Rare cancers through the looking glass

June 23, 2017 Medical Communications, Research and Development pharmafile, rare cancer

Rare cancers are not so rare after all. According to the organisation Rare Cancer Europe more than 4.3 million people …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …

FDA’s Gottlieb draws those ‘gaming’ system into pricing debate

June 22, 2017 Medical Communications, Sales and Marketing Drug pricing, FDA, Trump

President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now …

Thermo Fisher Scientific announces single quadrupole mass spectrometer and specialised columns

June 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Thermo Fisher Scientific Inc., the world leader in serving science, today announced new technologies that are designed to allow analytical …

Making strides in hepatitis

June 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Johnson & Johnson

Pharmafocus caughtup with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss the progress being made in the …
The Gateway to Local Adoption Series

Latest content